- Compliance Services
- Cybersecurity & Risk
- Performance Services
- Technology Solutions
- Events & Education
In 2014, the U.S. Securities and Exchange Commission (SEC) announced a sustained commitment to revolutionize its National Examination Program and Enforcement Division through the extensive use of technology to detect and combat wrongdoing, including insider trading and market manipulation. Over the past several months, we have observed the SEC staff’s technology commitment in action through various public statements and the announcement of a number of enforcement actions (both settled and ongoing) against registered investment advisers. To highlight:
We believe the SEC will continue to make substantial investments in its data analytics and surveillance tools. As a result, the old way of conducting compliance surveillance and testing through manual processes and sampling techniques will need to evolve and change with the times.
How ACA Can Help
ACA offers Decryptex®, our proprietary algorithmic-based data analytics software that provides firms with surveillance tools to facilitate more rigorous and robust oversight over their investing activities. Decryptex's algorithms test an adviser’s trading and investment positions for, among other things, issues related to the misuse of material non-public information, market manipulation, fairness in dealing, abusive personal trading, inappropriate allocations, and violate short selling. Decryptex provides firms with the tools necessary to satisfy ever-increasing regulatory demands and ensure the implementation of reasonably designed and effectively implemented compliance oversight procedures.
Attend our Upcoming Webcast on November 30
Join ACA's Ted Eichenlaub and Michael Lehman on November 30 at 11 a.m. EST for a webcast that will discuss the regulatory focus on trade surveillance and provide a demonstration of ACA's Decryptex. Click the button below to register.
For More Information
If you have any questions about the SEC's focus on trade surveillance or ACA's Decryptex, please contact Michael Lehman or your ACA consultant.